Cherry CL - Search Results

1

Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.

Cherry CL, Affandi JS, Brew BJ, Creighton J, Djauzi S, Hooker DJ, Imran D, Kamarulzaman A, Kamerman P, McArthur JC, Moore RD, Price P, Smyth K, Tan IL, Vanar S, Wadley A, Wesselingh SL, Yunihastuti E. Cherry CL, et al. Neurology. 2010 May 11;74(19):1538-42. doi: 10.1212/WNL.0b013e3181dd436d. Neurology. 2010. PMID: 20458071 Free PMC article.

2

Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region.

Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S. Wright E, et al. Neurology. 2008 Jul 1;71(1):50-6. doi: 10.1212/01.wnl.0000316390.17248.65. Neurology. 2008. PMID: 18591505

3

Painful HIV-associated sensory neuropathy.

Cherry CL, Wadley AL, Kamerman PR. Cherry CL, et al. Pain Manag. 2012 Nov;2(6):543-52. doi: 10.2217/pmt.12.67. Pain Manag. 2012. PMID: 24645886

4

Nucleoside analogues and neuropathy in the era of HAART.

Cherry CL, McArthur JC, Hoy JF, Wesselingh SL. Cherry CL, et al. J Clin Virol. 2003 Feb;26(2):195-207. doi: 10.1016/s1386-6532(02)00118-x. J Clin Virol. 2003. PMID: 12600651 Review.

5

Evaluation of a clinical screening tool for HIV-associated sensory neuropathies.

Cherry CL, Wesselingh SL, Lal L, McArthur JC. Cherry CL, et al. Neurology. 2005 Dec 13;65(11):1778-81. doi: 10.1212/01.wnl.0000187119.33075.41. Neurology. 2005. PMID: 16344522 Clinical Trial.

6

Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk.

Cherry CL, Rosenow A, Affandi JS, McArthur JC, Wesselingh SL, Price P. Cherry CL, et al. AIDS Res Hum Retroviruses. 2008 Feb;24(2):117-23. doi: 10.1089/aid.2007.0168. AIDS Res Hum Retroviruses. 2008. PMID: 18240960

7

Diagnosing and treating HIV-associated sensory neuropathy: a global perspective.

Cherry CL, Wadley AL, Kamerman PR. Cherry CL, et al. Pain Manag. 2016 Apr;6(2):191-9. doi: 10.2217/pmt.15.65. Epub 2016 Mar 18. Pain Manag. 2016. PMID: 26988147 Review.

8

Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006.

Smyth K, Affandi JS, McArthur JC, Bowtell-Harris C, Mijch AM, Watson K, Costello K, Woolley IJ, Price P, Wesselingh SL, Cherry CL. Smyth K, et al. Among authors: cherry cl. HIV Med. 2007 Sep;8(6):367-73. doi: 10.1111/j.1468-1293.2007.00478.x. HIV Med. 2007. PMID: 17661844 Free article.

9

Age and height predict neuropathy risk in patients with HIV prescribed stavudine.

Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P. Cherry CL, et al. Neurology. 2009 Jul 28;73(4):315-20. doi: 10.1212/WNL.0b013e3181af7a22. Neurology. 2009. PMID: 19636052

10

Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort.

Cherry CL, Skolasky RL, Lal L, Creighton J, Hauer P, Raman SP, Moore R, Carter K, Thomas D, Ebenezer GJ, Wesselingh SL, McArthur JC. Cherry CL, et al. Neurology. 2006 Mar 28;66(6):867-73. doi: 10.1212/01.wnl.0000203336.12114.09. Neurology. 2006. PMID: 16567704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters